PharmaBoardroom

In a market environment that, up until recently, has been severely difficult for producers of chemical pharmaceutical products to operate in, three…

Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities…

Vytautas Baublys, co-founder and CEO of Softneta, introduces the award-winning Lithuanian IT company, and its service offering, explaining how…

Nadurel Pharma, headquartered in the technopole of Saint-Hyacinthe, Quebec, promotes natural health products complete with concrete clinical trial…

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of…

Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and…

Janis Silins of the Association of Biopharmaceutical Drug Manufacturers in Latvia discusses the organization’s purpose, collaboration efforts, and…

Roberto Aspiazu, executive director of the Ecuadorian Business Committee and honorary president of the Mexican Chamber of Commerce in Ecuador,…

Jaiveer Singh, CEO of Mint Pharmaceuticals explains the company’s business model and how it fits the characteristics of the Canadian market on the…

Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for reimbursement in Serbia, compared…

Jūratė Sabalienė, who was appointed in September 2017 as the director of the National Health Insurance Fund (NHIF) of the Republic of Lithuania,…

Iwona Skrzekowska-Baran, owner and CEO of Pharm&Med, a young, exciting Polish consultancy that is helping clients to transform evidence, policy…